Skip to main content
. 2021 Dec 6;12:788558. doi: 10.3389/fphar.2021.788558

FIGURE 8.

FIGURE 8

Effect of UDCA treatment on hepatic bile acid–related genes expression in NASH mice. (A) UDCA treatment did not activate the suppressed FXR signal pathway in NASH mice. (B) Proposed mechanism of UDCA treatment alleviating hepatic inflammation in NASH mice. Values represent mean ± standard deviation with *p < 0.05, **p < 0.01, and not significant (ns) vs HFHC_12w group. Abbreviation: UDCA, ursodeoxycholic acid; NASH, non-alcoholic steatohepatitis; FXR, farnesoid X receptor; HFHC, high-fat high-cholesterol.